Cardiovascular malformations in Smith-Lemli-Opitz syndrome

Angela E. Lin, Holly H. Ardinger, Robert H. Ardinger, Christopher M Cunniff, Richard I. Kelley

Research output: Contribution to journalArticle

63 Citations (Scopus)

Abstract

We reviewed 215 patients (59 new, 156 from the literature) with Smith- Lemli-Opitz syndrome (SLOS), and found that 95 (44%) had a cardiovascular malformation (CVM). Classifying CVMs by disordered embryonic mechanisms, there were 5 (5.3%) class I (ectomesenchymal tissue migration abnormalities), 56 (58.9%) class II (abnormal intracardiac blood flow), 25 (26.3%) class IV (abnormal extracellular matrix), and 5 (5.3%) class V (abnormal targeted growth). Comparing the frequencies of individual CVMs in this series with a control group (the Baltimore-Washington Infant Study), there were 6 individual CVMs which showed a significant difference from expected values. When frequencies of CVMs in SLOS were analyzed by mechanistic class, classes IV and V were significantly more frequent, and class I significantly less frequent, than the control group. Although CVMs in SLOS display mechanistic heterogeneity, with an overall predominance of class II CVMs, the developmental error appears to favor alteration of the cardiovascular developmental mechanisms underlying atrioventricular canal and anomalous pulmonary venous return. This information should assist the clinical geneticist evaluating a patient with possible SLOS, and should suggest research direction for the mechanisms responsible for the SLOS phenotype.

Original languageEnglish (US)
Pages (from-to)270-278
Number of pages9
JournalAmerican Journal of Medical Genetics
Volume68
Issue number3
DOIs
StatePublished - 1997
Externally publishedYes

Fingerprint

Smith-Lemli-Opitz Syndrome
Scimitar Syndrome
Baltimore
Control Groups
Extracellular Matrix
Phenotype
Growth
Research

Keywords

  • anomalous pulmonary venous return
  • atrioventricular canal
  • cardiovascular malformation
  • congenital heart defect
  • MCA/MR syndrome
  • mechanistic classification
  • Smith-Lemli-Opitz syndrome

ASJC Scopus subject areas

  • Genetics(clinical)

Cite this

Cardiovascular malformations in Smith-Lemli-Opitz syndrome. / Lin, Angela E.; Ardinger, Holly H.; Ardinger, Robert H.; Cunniff, Christopher M; Kelley, Richard I.

In: American Journal of Medical Genetics, Vol. 68, No. 3, 1997, p. 270-278.

Research output: Contribution to journalArticle

Lin, Angela E. ; Ardinger, Holly H. ; Ardinger, Robert H. ; Cunniff, Christopher M ; Kelley, Richard I. / Cardiovascular malformations in Smith-Lemli-Opitz syndrome. In: American Journal of Medical Genetics. 1997 ; Vol. 68, No. 3. pp. 270-278.
@article{1fec749636fd42cdb7e0b0ee60e20a7d,
title = "Cardiovascular malformations in Smith-Lemli-Opitz syndrome",
abstract = "We reviewed 215 patients (59 new, 156 from the literature) with Smith- Lemli-Opitz syndrome (SLOS), and found that 95 (44{\%}) had a cardiovascular malformation (CVM). Classifying CVMs by disordered embryonic mechanisms, there were 5 (5.3{\%}) class I (ectomesenchymal tissue migration abnormalities), 56 (58.9{\%}) class II (abnormal intracardiac blood flow), 25 (26.3{\%}) class IV (abnormal extracellular matrix), and 5 (5.3{\%}) class V (abnormal targeted growth). Comparing the frequencies of individual CVMs in this series with a control group (the Baltimore-Washington Infant Study), there were 6 individual CVMs which showed a significant difference from expected values. When frequencies of CVMs in SLOS were analyzed by mechanistic class, classes IV and V were significantly more frequent, and class I significantly less frequent, than the control group. Although CVMs in SLOS display mechanistic heterogeneity, with an overall predominance of class II CVMs, the developmental error appears to favor alteration of the cardiovascular developmental mechanisms underlying atrioventricular canal and anomalous pulmonary venous return. This information should assist the clinical geneticist evaluating a patient with possible SLOS, and should suggest research direction for the mechanisms responsible for the SLOS phenotype.",
keywords = "anomalous pulmonary venous return, atrioventricular canal, cardiovascular malformation, congenital heart defect, MCA/MR syndrome, mechanistic classification, Smith-Lemli-Opitz syndrome",
author = "Lin, {Angela E.} and Ardinger, {Holly H.} and Ardinger, {Robert H.} and Cunniff, {Christopher M} and Kelley, {Richard I.}",
year = "1997",
doi = "10.1002/(SICI)1096-8628(19970131)68:3<270::AID-AJMG5>3.0.CO;2-Q",
language = "English (US)",
volume = "68",
pages = "270--278",
journal = "American Journal of Medical Genetics, Part A",
issn = "1552-4825",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Cardiovascular malformations in Smith-Lemli-Opitz syndrome

AU - Lin, Angela E.

AU - Ardinger, Holly H.

AU - Ardinger, Robert H.

AU - Cunniff, Christopher M

AU - Kelley, Richard I.

PY - 1997

Y1 - 1997

N2 - We reviewed 215 patients (59 new, 156 from the literature) with Smith- Lemli-Opitz syndrome (SLOS), and found that 95 (44%) had a cardiovascular malformation (CVM). Classifying CVMs by disordered embryonic mechanisms, there were 5 (5.3%) class I (ectomesenchymal tissue migration abnormalities), 56 (58.9%) class II (abnormal intracardiac blood flow), 25 (26.3%) class IV (abnormal extracellular matrix), and 5 (5.3%) class V (abnormal targeted growth). Comparing the frequencies of individual CVMs in this series with a control group (the Baltimore-Washington Infant Study), there were 6 individual CVMs which showed a significant difference from expected values. When frequencies of CVMs in SLOS were analyzed by mechanistic class, classes IV and V were significantly more frequent, and class I significantly less frequent, than the control group. Although CVMs in SLOS display mechanistic heterogeneity, with an overall predominance of class II CVMs, the developmental error appears to favor alteration of the cardiovascular developmental mechanisms underlying atrioventricular canal and anomalous pulmonary venous return. This information should assist the clinical geneticist evaluating a patient with possible SLOS, and should suggest research direction for the mechanisms responsible for the SLOS phenotype.

AB - We reviewed 215 patients (59 new, 156 from the literature) with Smith- Lemli-Opitz syndrome (SLOS), and found that 95 (44%) had a cardiovascular malformation (CVM). Classifying CVMs by disordered embryonic mechanisms, there were 5 (5.3%) class I (ectomesenchymal tissue migration abnormalities), 56 (58.9%) class II (abnormal intracardiac blood flow), 25 (26.3%) class IV (abnormal extracellular matrix), and 5 (5.3%) class V (abnormal targeted growth). Comparing the frequencies of individual CVMs in this series with a control group (the Baltimore-Washington Infant Study), there were 6 individual CVMs which showed a significant difference from expected values. When frequencies of CVMs in SLOS were analyzed by mechanistic class, classes IV and V were significantly more frequent, and class I significantly less frequent, than the control group. Although CVMs in SLOS display mechanistic heterogeneity, with an overall predominance of class II CVMs, the developmental error appears to favor alteration of the cardiovascular developmental mechanisms underlying atrioventricular canal and anomalous pulmonary venous return. This information should assist the clinical geneticist evaluating a patient with possible SLOS, and should suggest research direction for the mechanisms responsible for the SLOS phenotype.

KW - anomalous pulmonary venous return

KW - atrioventricular canal

KW - cardiovascular malformation

KW - congenital heart defect

KW - MCA/MR syndrome

KW - mechanistic classification

KW - Smith-Lemli-Opitz syndrome

UR - http://www.scopus.com/inward/record.url?scp=0031056983&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031056983&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1096-8628(19970131)68:3<270::AID-AJMG5>3.0.CO;2-Q

DO - 10.1002/(SICI)1096-8628(19970131)68:3<270::AID-AJMG5>3.0.CO;2-Q

M3 - Article

VL - 68

SP - 270

EP - 278

JO - American Journal of Medical Genetics, Part A

JF - American Journal of Medical Genetics, Part A

SN - 1552-4825

IS - 3

ER -